Keywords
How to Cite
Abstract
Introduction: Meningococcal meningitis, a condition of significant public health relevance, stands out as an inflammatory disorder of the membranes surrounding the brain and spinal cord, caused by the bacterium Neisseria meningitidis.
Methodology: The methodology adopted for the realization of this systematic review on meningococcal meningitis was based on the search for updated scientific evidence in the PUBMED database. The MESH descriptors used for the research were "Meningococcal Infections," "Epidemiology," "prevention and control," aiming to encompass the epidemiological aspects, risk factors, diagnostic methods, and prevention strategies associated with the disease.
Results: The complexity of the risk factors associated with meningococcal meningitis is revealed in a myriad of influences that range from intrinsic characteristics of the individual to behavioral and epidemiological aspects. The risk, to a large extent, is intertwined with individual characteristics, where age plays a preponderant role.
Conclusion: In conclusion, the holistic approach to meningococcal meningitis, examining its epidemiology, risk factors, diagnostic methods, and prevention strategies, reveals the intrinsic complexity of this pathology and the urgent need for in-depth understanding for its effective management.
References
Gruhn S, Witte J, Greiner W, Damm O, Dietzsch M, Kramer R, Knuf M. Epidemiology and economic burden of meningococcal disease in Germany: A systematic review. Vaccine. 2022 Mar 18;40(13):1932-1947. doi: 10.1016/j.vaccine.2022.02.043. Epub 2022 Feb 25. PMID: 35227520. Disponível: https://pubmed.ncbi.nlm.nih.gov/35227520/
Dogu AG, Oordt-Speets AM, van Kessel-de Bruijn F, Ceyhan M, Amiche A. Systematic review of invasive meningococcal disease epidemiology in the Eastern Mediterranean and North Africa region. BMC Infect Dis. 2021 Oct 22;21(1):1088. doi: 10.1186/s12879-021-06781-6. Erratum in: BMC Infect Dis. 2021 Nov 15;21(1):1160. PMID: 34686136; PMCID: PMC8540099. Disponível: https://pubmed.ncbi.nlm.nih.gov/34686136/
Peterson ME, Li Y, Bita A, Moureau A, Nair H, Kyaw MH; Meningococcal Surveillance Group (in alphabetical order); Abad R, Bailey F, Garcia IF, Decheva A, Krizova P, Melillo T, Skoczynska A, Vladimirova N. Meningococcal serogroups and surveillance: a systematic review and survey. J Glob Health. 2019 Jun;9(1):010409. doi: 10.7189/jogh.09.010409. PMID: 30603079; PMCID: PMC6304171. Disponível: https://pubmed.ncbi.nlm.nih.gov/30603079/
Santos-Neto JF, Ferreira VM, Feitosa CA, Martinez-Silveira MS, Campos LC. Carriage prevalence of Neisseria meningitidis in the Americas in the 21st century: a systematic review. Braz J Infect Dis. 2019 Jul-Aug;23(4):254-267. doi: 10.1016/j.bjid.2019.06.006. Epub 2019 Jul 22. PMID: 31344352; PMCID: PMC9427833. Disponível: https://pubmed.ncbi.nlm.nih.gov/31344352/
McMillan M, Chandrakumar A, Wang HLR, Clarke M, Sullivan TR, Andrews RM, Ramsay M, Marshall HS. Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021 Aug 2;73(3):e609-e619. doi: 10.1093/cid/ciaa1733. PMID: 33212510. Disponível: https://pubmed.ncbi.nlm.nih.gov/33212510/
Nwogu IB, Jones M, Langley T. Economic evaluation of meningococcal serogroup B (MenB) vaccines: A systematic review. Vaccine. 2021 Apr 15;39(16):2201-2213. doi: 10.1016/j.vaccine.2021.02.049. Epub 2021 Mar 18. PMID: 33744052. Disponível: https://pubmed.ncbi.nlm.nih.gov/33744052/
Kolobova I, Nyaku MK, Karakusevic A, Bridge D, Fotheringham I, O'Brien M. Burden of vaccine-preventable diseases among at-risk adult populations in the US. Hum Vaccin Immunother. 2022 Nov 30;18(5):2054602. doi: 10.1080/21645515.2022.2054602. Epub 2022 Apr 21. PMID: 35446725; PMCID: PMC9225203. Disponível: https://pubmed.ncbi.nlm.nih.gov/35446725/
Valmas C, Arcà E, Hensen M, Rashid H. A policy review of the introduction of the MenACWY vaccine in toddlers across multiple countries. Expert Rev Vaccines. 2022 Nov;21(11):1637-1646. doi: 10.1080/14760584.2022.2128771. Epub 2022 Oct 12. PMID: 36222056. Disponível: https://pubmed.ncbi.nlm.nih.gov/36222056/
Parikh SR, Campbell H, Mandal S, Ramsay ME, Ladhani SN. Primary meningococcal conjunctivitis: Summary of evidence for the clinical and public health management of cases and close contacts. J Infect. 2019 Dec;79(6):490-494. doi: 10.1016/j.jinf.2019.10.015. Epub 2019 Oct 25. PMID: 31669376. Disponível: https://pubmed.ncbi.nlm.nih.gov/31669376/
Jones JL, Tse F, Carroll MW, deBruyn JC, McNeil SA, Pham-Huy A, Seow CH, Barrett LL, Bessissow T, Carman N, Melmed GY, Vanderkooi OG, Marshall JK, Benchimol EI. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines. Gastroenterology. 2021 Aug;161(2):681-700. doi: 10.1053/j.gastro.2021.04.034. PMID: 34334167. Disponível: https://pubmed.ncbi.nlm.nih.gov/34334167/
Tin Tin Htar M, Jackson S, Balmer P, Serra LC, Vyse A, Slack M, Riera-Montes M, Swerdlow DL, Findlow J. Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs. BMC Public Health. 2020 Dec 9;20(1):1890. doi: 10.1186/s12889-020-09946-1. PMID: 33298015; PMCID: PMC7724720. Disponível: https://pubmed.ncbi.nlm.nih.gov/33298015/
Yue M, Xu J, Yu J, Shao Z. Carriage prevalence of Neisseria meningitidis in China, 2005-2022: a systematic review and meta-analysis. BMC Infect Dis. 2022 Jul 7;22(1):594. doi: 10.1186/s12879-022-07586-x. PMID: 35799100; PMCID: PMC9261068. Disponível: https://pubmed.ncbi.nlm.nih.gov/35799100/.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Renata Peruchi Carvalho, Mateus Fernandes Alves dos Reis, Gabriel Monteiro Amorim, Bárbara Almeida Nico, Raphael Morais Vasconcelos